On March 31, 2022, the ImagingNMD team joined PPMD for a community webinar to discuss the expansion of their imaging biomarker development work to patients living with Becker muscular dystrophy, building on the knowledge they have gained during the last 15 years in Duchenne.

The team highlighted the importance of developing sensitive measures and establishing the natural history of the disorder as therapies are being explored in Becker. Our presenters also shared initial results in participants with Becker and explained the inclusion criteria for the study that is now open for enrollment.